Dynamic expression of TRAIL DRs is one of the most widely investigated mechanisms for TRAIL-based therapy resistance because lack of surface DRs is sufficient to render cancer cells resistant to TRAIL-induced apoptosis regardless of the status of other apoptosis signaling mechanisms. This evidence concerns the gene TNFSF10 and cancer.